Q2 2021 13F Holders as of 30 Jun 2021
-
Type / Class
-
Equity / COM
-
Shares outstanding
-
40,762,262
-
Number of holders
-
112
-
Total 13F shares, excl. options
-
25,771,799
-
Shares change
-
+4,983,023
-
Total reported value, excl. options
-
$1,136,970,052
-
Value change
-
+$216,275,676
-
Number of buys
-
82
-
Number of sells
-
-50
-
Price
-
$44.12
Significant Holders of Pulmonx Corp - COM (LUNG) as of Q2 2021
147 filings reported holding LUNG - Pulmonx Corp - COM as of Q2 2021.
Pulmonx Corp - COM (LUNG) has 112 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 25,771,799 shares
of 40,762,262 outstanding shares and own 63.22% of the company stock.
Largest 10 shareholders include Capital World Investors (2,550,500 shares), BlackRock Inc. (2,323,639 shares), PRIMECAP MANAGEMENT CO/CA/ (1,959,343 shares), VANGUARD GROUP INC (1,888,275 shares), DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) (1,800,887 shares), RTW INVESTMENTS, LP (1,129,600 shares), Champlain Investment Partners, LLC (1,065,015 shares), GILDER GAGNON HOWE & CO LLC (1,045,702 shares), KPCB XIII Associates, LLC (994,971 shares), and Point72 Asset Management, L.P. (660,801 shares).
This table shows the top 112 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.